Rapport Therapeutics, Inc.
Historical 13F Holders
Symbol
RAPP
CUSIP
75383L102
All holders as of
Q4 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period
Filings
Shares, Excl. Options
Value, Excl. Options
Options Value
2025 Q4
145
48.9 M
$1.48 B
$1.30 M
2025 Q3
133
49.3 M
$1.46 B
$12.7 M
2025 Q2
83
38.5 M
$438 M
$0
2025 Q1
80
38.1 M
$382 M
$30.1 k
2024 Q4
71
36.6 M
$649 M
$0
2024 Q3
57
28.4 M
$582 M
$0
2024 Q2
36
25.6 M
$593 M
$0